Slideshow of doctors

GORE® VIABAHN® Device family

Join the next generation of care in the treatment of aortoiliac occlusive disease

Durable outcomes even in the most complex cases

Aortoiliac bifurcation (kissing stent technique) lesions
Moderate to severely calcified focal or diffuse lesions
Diffuse iliac artery lesions

 

Aortoiliac bifurcation (kissing stent technique) lesions

Common challenges:

  • Plaque shift
  • Embolization concerns
  • Flow dynamics
  • Tapered anatomy
  • Rupture risk

The GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis (VBX Stent Graft) delivers:

Case example

Before

Before

After

After

Freedom from target lesion revascularization (fTLR) in kissing stents (N = 118)†

fTLR Kissing graphic

† Data on file 2020; W. L. Gore & Associates, Inc; Flagstaff, AZ.

Moderate to severely calcified focal or diffuse lesions

Common challenges:

  • Sufficient radial strength
  • Embolization concerns
  • Need for reintervention
  • Rupture risk

The VBX Stent Graft delivers:

Case example

Before and After

 

fTLR in TASC II C and D lesions (N = 77)†

TASC Graphic

† Data on file 2020; W. L. Gore & Associates, Inc; Flagstaff, AZ.

Diffuse iliac artery lesions

Common challenges:

  • Embolization concerns
  • Conformability
  • Need for reintervention (e.g., neointimal hyperplasia)
  • Rupture risk
  • Deployment accuracy
  • Tortuosity
  • Vessel movement
  • Embolization concerns

The GORE® VIABAHN® Endoprosthesis with PROPATEN Bioactive Surface* delivers:

Case example

Before

Before

After

After
  • Single wire nitinol frame for flexibility, trackability and fracture resistance.
  • CBAS Heparin Surface for lasting thromboresistance.1
  • ePTFE graft covers and excludes disease.

*As used by Gore, PROPATEN Bioactive Surface refers to Gore’s proprietary CBAS Heparin Surface.

† Data on file 2020; W. L. Gore & Associates, Inc; Flagstaff, AZ.

  1. CBAS Heparin Surface. W. L. Gore & Associates website. Accessed February 11,2021. https://www.goremedical.com/cbas/references

eIFU Symbol

Refer to Instructions for Use at eifu.goremedical.com for a complete description of all applicable indications, warnings, precautions and contraindications for the markets where this product is available. RXOnly

Residents of some states have the right to opt-out of the “sharing” or “selling” of their personal information. Gore does not "sell" the personal information of website users. Gore may "share" the personal information of website users, as standard advertising practice meant to offer you a more personalized service.

If you want to opt-out from Gore “sharing” your personal information, click on Opt-Out of Sharing to turn off the targeting cookies that we share with our advertising partners in order to provide you with personalized information. Disabling sharing will stop the use of cookies to targeted advertising but you may still see generic Gore ads.

Please note that your exercising of the rights outlined will have no adverse effect on the price and quality of our goods or services.

Opt-Out of Sharing

You Have Successfully Opted Out of the Sharing of Your Personal Information

Please note that if you clear your cookies and then use another device or browser, etc. your opt-out status is not transferred to the new device or browser.